CEUFX
Price
$66.54
Change
+$0.35 (+0.53%)
Updated
Jun 2 closing price
Net Assets
136.57B
GONCX
Price
$37.48
Change
+$0.23 (+0.62%)
Updated
Jun 2 closing price
Net Assets
6.37B
Interact to see
Advertisement

CEUFX vs GONCX

Header iconCEUFX vs GONCX Comparison
Open Charts CEUFX vs GONCXBanner chart's image
CEUFX vs GONCX Comparison Chart in %
View a ticker or compare two or three
VS
CEUFX vs. GONCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEUFX is a Hold and GONCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CEUFX has more cash in the bank: 137B vs. GONCX (6.37B). CEUFX pays higher dividends than GONCX: CEUFX (2.64) vs GONCX (0.00). CEUFX was incepted earlier than GONCX: CEUFX (24 years) vs GONCX (20 years). GONCX (2.00) is less costly to investors than CEUFX (0.91). GONCX is a more actively managed with annual turnover of: 65.00 vs. CEUFX (35.00). CEUFX has a lower initial minimum investment than GONCX: CEUFX (250) vs GONCX (1000). GONCX annual gain was more profitable for investors over the last year : 25.17 vs. CEUFX (14.83). CEUFX return over 5 years is better than : -0.11 vs. GONCX (-2.89).
CEUFXGONCXCEUFX / GONCX
Total Expense Ratio0.912.0046%
Annual Report Gross Expense Ratio0.912.0046%
Fund Existence24 years20 years-
Gain YTD11.65713.39487%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets137B6.37B2,150%
Annual Yield % from dividends2.640.00-
Returns for 1 year14.8325.1759%
Returns for 3 years32.4866.2949%
Returns for 5 years-0.11-2.894%
Returns for 10 years71.2177.9191%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCSG20.240.30
+1.50%
Healthcare Services Group
SONY22.790.22
+0.97%
Sony Group Corporation
LNTH96.30-0.83
-0.85%
Lantheus Holdings
AWRE1.47-0.03
-2.00%
Aware
ELDN3.53-0.23
-6.12%
Eledon Pharmaceuticals